“…Its immediate and prolonged effect, the increase in uteroplacental flow that occurs with the reduction in uterine vascular resistance [27], and the rarity of maternal and fetal side effects lead to it being frequently used [6,28,29]. Nevertheless, there is wide interpatient variability in the dose of labetalol required to control BP, an event that is not predictable by any clinical item before therapy.…”